Cristescu, R., Liu, X. Q., Arreaza, G., Chen, C., Albright, A., Qiu, P., & Marton, M. J. (2022). Concordance between single-nucleotide polymorphism–based genomic instability assays and a next-generation sequencing–based homologous recombination deficiency test. BMC cancer, 22(1), 1310-9. https://doi.org/10.1186/s12885-022-10197-z
Citace podle Chicago (17th ed.)Cristescu, Razvan, Xiao Qiao Liu, Gladys Arreaza, Cai Chen, Andrew Albright, Ping Qiu, a Matthew J. Marton. "Concordance Between Single-nucleotide Polymorphism–based Genomic Instability Assays and a Next-generation Sequencing–based Homologous Recombination Deficiency Test." BMC Cancer 22, no. 1 (2022): 1310-9. https://doi.org/10.1186/s12885-022-10197-z.
Citace podle MLA (9th ed.)Cristescu, Razvan, et al. "Concordance Between Single-nucleotide Polymorphism–based Genomic Instability Assays and a Next-generation Sequencing–based Homologous Recombination Deficiency Test." BMC Cancer, vol. 22, no. 1, 2022, pp. 1310-9, https://doi.org/10.1186/s12885-022-10197-z.